{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T07:59:26Z","timestamp":1775116766613,"version":"3.50.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,7,1]],"date-time":"2012-07-01T00:00:00Z","timestamp":1341100800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T00:00:00Z","timestamp":1670284800000},"content-version":"vor","delay-in-days":3810,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2012,7]]},"DOI":"10.1111\/j.1538-7836.2012.04747.x","type":"journal-article","created":{"date-parts":[[2012,4,16]],"date-time":"2012-04-16T12:57:37Z","timestamp":1334581057000},"page":"1425-1432","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease"],"prefix":"10.1016","volume":"10","author":[{"given":"V.H.","family":"FLOOD","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.C.","family":"GILL","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.A.","family":"CHRISTOPHERSON","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.S.","family":"WREN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.D.","family":"FRIEDMAN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.L.","family":"HABERICHTER","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.G.","family":"HOFFMANN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.R.","family":"MONTGOMERY","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0010","doi-asserted-by":"crossref","first-page":"13835","DOI":"10.1016\/S0021-9258(19)76501-6","article-title":"Isolation and characterization of two domains of human von Willebrand factor that interact with fibrillar collagen types I and III","volume":"262","author":"Pareti","year":"1987","journal-title":"J Biol Chem"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0015","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1042\/bj3240185","article-title":"von Willebrand factor binds to native collagen VI primarily via its A1 domain","volume":"324","author":"Hoylaerts","year":"1997","journal-title":"Biochem J"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0020","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/0049-3848(86)90150-7","article-title":"An ELISA test for the binding of von Willebrand antigen to collagen","volume":"43","author":"Brown","year":"1986","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0025","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1055\/s-2002-27821","article-title":"von Willebrand factor collagen\u2010binding (activity) assay in the diagnosis of von Willebrand disease: a 15\u2010year journey","volume":"28","author":"Favaloro","year":"2002","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0030","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1055\/s-0037-1613768","article-title":"Collagen binding assay for von Willebrand factor (VWF:CBA): detection of von Willebrands Disease (VWD), and discrimination of VWD subtypes, depends on collagen source","volume":"83","author":"Favaloro","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0035","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1055\/s-0037-1614188","article-title":"Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease \u2013 single center comparison of four different assays","volume":"84","author":"Federici","year":"2000","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0040","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1055\/s-2007-1000364","article-title":"An update on the von Willebrand factor collagen binding assay: 21\u2003years of age and beyond adolescence but not yet a mature adult","volume":"33","author":"Favaloro","year":"2007","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0045","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1055\/s-2006-947866","article-title":"Laboratory testing for von Willebrand disease: contribution of multimer analysis to diagnosis and classification","volume":"32","author":"Budde","year":"2006","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0050","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/j.1365-2516.2007.01643.x","article-title":"von Willebrand disease (VWD): evidence\u2010based diagnosis and management guidelines, the National Heart, Lung, and Blood Institute (NHLBI) Expert Panel report (USA)","volume":"14","author":"Nichols","year":"2008","journal-title":"Haemophilia"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0055","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1172\/JCI115285","article-title":"150\u2010kD von Willebrand factor binding protein extracted from human vascular subendothelium is type VI collagen","volume":"88","author":"Rand","year":"1991","journal-title":"J Clin Invest"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0060","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1182\/blood-2009-10-249102","article-title":"Common VWF exon 28 polymorphisms in African Americans affecting the VWF activity assay by ristocetin cofactor","volume":"116","author":"Flood","year":"2010","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0065","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1182\/blood.V60.1.201.201","article-title":"A variant of von Willebrand\u2019s disease with abnormal expression of factor VIII procoagulant activity","volume":"60","author":"Montgomery","year":"1982","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0070","doi-asserted-by":"crossref","first-page":"4979","DOI":"10.1182\/blood-2007-09-110940","article-title":"Identification of type 1 von Willebrand disease patients with reduced von Willebrand factor survival by assay of the VWF propeptide in the European study: molecular and clinical markers for the diagnosis and management of type 1 VWD (MCMDM\u20101VWD)","volume":"111","author":"Haberichter","year":"2008","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0075","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1046\/j.1538-7836.2003.00367.x","article-title":"Measurement of von Willebrand factor activity: relative effects of ABO blood type and race","volume":"1","author":"Miller","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0080","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1309\/W76QF806CE80CL2T","article-title":"Reassessment of ABO blood group, sex, and age on laboratory parameters used to diagnose von Willebrand disorder: potential influence on the diagnosis vs the potential association with risk of thrombosis","volume":"124","author":"Favaloro","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0085","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.1182\/blood.V88.7.2559.bloodjournal8872559","article-title":"Type 2M:Milwaukee\u20101 von Willebrand disease: an in\u2010frame deletion in the Cys509\u2010Cys695 loop of the von Willebrand factor A1 domain causes deficient binding of von Willebrand factor to platelets","volume":"88","author":"Mancuso","year":"1996","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0090","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1055\/s-0029-1214149","article-title":"Toward a new paradigm for the identification and functional characterization of von Willebrand disease","volume":"35","author":"Favaloro","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0095","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1182\/blood-2009-01-153296","article-title":"How I treat von Willebrand disease","volume":"114","author":"Rodeghiero","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0100","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1160\/TH10-06-0360","article-title":"Evaluation of commercial von Willebrand factor collagen binding assays to assist the discrimination of types 1 and 2 von Willebrand disease","volume":"104","author":"Favaloro","year":"2010","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0105","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/01.ATV.13.3.398","article-title":"Localization of von Willebrand factor binding domains to endothelial extracellular matrix and to type VI collagen","volume":"13","author":"Denis","year":"1993","journal-title":"Arterioscler Thromb"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0110","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1055\/s-0038-1657567","article-title":"The significance of subendothelial von Willebrand factor","volume":"78","author":"Rand","year":"1997","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0115","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ajh.10238","article-title":"Effect of ABO blood group on the collagen\u2010binding assay for von Willebrand factor","volume":"71","author":"Haley","year":"2002","journal-title":"Am J Hematol"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0120","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1046\/j.1538-7836.2003.00007.x","article-title":"An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13","volume":"1","author":"Bowen","year":"2003","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0125","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1160\/TH06-07-0383","article-title":"An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease","volume":"96","author":"Cumming","year":"2006","journal-title":"Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0130","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1182\/blood-2006-05-020784","article-title":"Phenotype and genotype of a cohort of families historically diagnosed with type 1 von Willebrand disease in the European study, Molecular and Clinical Markers for the Diagnosis and Management of Type 1 von Willebrand Disease (MCMDM\u20101VWD)","volume":"10","author":"Goodeve","year":"2007","journal-title":"Blood"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0135","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1016\/j.thromres.2011.09.030","article-title":"Coating conditions matter to collagen matrix formation regarding von Willebrand factor and platelet binding","volume":"129","author":"Mendelboum Raviv","year":"2012","journal-title":"Thromb Res"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0140","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1111\/j.1538-7836.2006.01823.x","article-title":"Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD","volume":"4","author":"Eikenboom","year":"2006","journal-title":"J Thromb Haemost"},{"key":"10.1111\/j.1538-7836.2012.04747.x_bb0145","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2006.01847.x","article-title":"A quantitative analysis of bleeding symptoms in type 1 von Willebrand disease: results from a multicenter European study (MCMDM\u20101 VWD)","volume":"4","author":"Tosetto","year":"2006","journal-title":"J Thromb Haemost"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1538-7836.2012.04747.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622063395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783622063395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/j.1538-7836.2012.04747.x\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T02:59:42Z","timestamp":1761533982000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783622063395"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7]]},"references-count":28,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2012,7]]}},"alternative-id":["S1538783622063395"],"URL":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04747.x","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2012,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of type I, type III and type VI collagen binding assays in diagnosis of von Willebrand disease","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1111\/j.1538-7836.2012.04747.x","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 International Society on Thrombosis and Haemostasis. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}